Abstract: the study provides an assessment of the efficiency and safety of superselective prostate artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH), in patients with comorbidities and high surgical risk for traditional endourethral interventions. The study group included 162 patients, whose average age was 69.4 years. After performing the PAE, the prostate volume decreased on average by 23.3% (in the long-term period), the dynamics of improvement in the maximum urination rate was 1.61 times (the peak urinary flow (Qmax) increased on average from 8 ml/s to 12.9 ml /s). According to IPSS and QoL testing, the average number of points decreased from 24.9 to 12.1 (improvement by 51.4%) and from 5.3 to 2.4 (improvement by 54.7%). The PAE, while remaining a relatively young method in the structure of the surgical treatment of BPH, can be considered effective and relatively safe in treating patients with high surgical risk on the background of comorbidities.
Keywords: benign prostatic hyperplasia, embolization of the prostatic arteries, high surgical risk